Clinicians should maintain vigilance for TB symptoms in immunosuppressed patients and collaborate with TB specialists to optimize treatment strategies, reinforcing the importance of preventive measures in mitigating the risks associated with anti-TNF therapy. The gene discussed is TNF; the disease is tuberculosis.